beta-hydroxyisovalerylshikonin has been researched along with Cancer of Lung in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kajimoto, S; Nakajo, S; Nakaya, K; Xu, Y | 1 |
| Gong, XF; Horie, M; Itabe, H; Kajimoto, S; Manabe, H; Masuda, Y; Nakajo, S; Nakaya, K; Obama, T; Shibayama-Imazu, T | 1 |
2 other study(ies) available for beta-hydroxyisovalerylshikonin and Cancer of Lung
| Article | Year |
|---|---|
Beta-hydroxyisovalerylshikonin and cisplatin act synergistically to inhibit growth and to induce apoptosis of human lung cancer DMS114 cells via a tyrosine kinase-dependent pathway.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cisplatin; Drug Synergism; Humans; In Situ Nick-End Labeling; Lung Neoplasms; Naphthoquinones; Protein-Tyrosine Kinases; Tumor Cells, Cultured | 2004 |
A tyrosine kinase inhibitor, beta-hydroxyisovalerylshikonin, induced apoptosis in human lung cancer DMS114 cells through reduction of dUTP nucleotidohydrolase activity.
Topics: Amino Acid Sequence; Antineoplastic Agents; Antioxidants; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxyuracil Nucleotides; Enzyme Activation; Fluorouracil; Humans; Lung Neoplasms; Molecular Sequence Data; Naphthoquinones; Phosphoproteins; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrophosphatases; RNA, Small Interfering | 2008 |